DNA FETAL LIBRE EN EL PLASMA MATERNO Y DIAGNÓSTICO PRENATAL NO INVASIVO

La naturaleza no invasiva de la investigación del DNA fetal en la circulación materna representa una ventaja importante con relación a los métodos convencionales de diagnóstico prenatal. El uso de esta metodología implica la determinación del sexo fetal y el diagnóstico, el tratamiento intra-útero y la evaluación del pronóstico en muchas enfermedades. Las células fetales detectadas en la circulación maternal también pueden ser
implicadas en enfermedades autoinmunes y representar una fuente potencial de células madre. Por otra parte, con la introducción de una tecnología que detecte el sexo fetal entre [6] [7] [8] All pregnant women have the potential risk to present an embryo with anomalies. Therefore, maternal age should be taken into consideration in all pregnancies and fetal morphologic ultrasonography and biochemical tests in maternal blood should always be carried out (1) . However, in special cases, there is the need to use invasive methods, such as chorionic villus sampling (CVS) or amniocentesis, which represents a higher risk for the embryo (2) . For this reason, the technologies involving prenatal diagnosis continue to evolve, with emphasis on research for the development and improvement of noninvasive techniques.
FETAL CELLS IN THE MATERNAL CIRCULATION
The detection of fetal cells in maternal lung parenchyma associated with eclampsia has been described since the 19th century (3) , but the presence of these cells in maternal peripheral blood continues to be the subject of intense research. Fetal cells appear early in the maternal circulation during the first trimester and continue to be present throughout gestation. However, the isolation of fetal cells from the maternal circulation is still technically complex. Fetal cells can be present in maternal blood at a ratio of 1:100,000 maternal cells or less (or approximately one per ml of maternal blood in euploid pregnancies) (4) .
Another problem, in addition to their small numbers, is the permanence of fetal cells in maternal circulation after the pregnancy. There is a report of the detection of nuclear male DNA in a woman who had her last son 27 years before the study (5) . Other investigations have
shown that the persistent cells could have an important role in women's autoimmune diseases. On the other hand, these cells appear to have stem cell characteristics, such as the ability to proliferate and differentiate, which could be of benefit to the mothers (4) .
CELL-FREE FETAL DNA IN MATERNAL PLASMA
The quantitative analysis of the free fetal DNA demonstrated that this can compose up to 6.2% of the total DNA present in the maternal plasma (6) .
Apoptosis would partially explain the disappearance of fetal DNA from maternal circulation after birth, since this is a fast reaction, concluded within 2 to 3 hours after childbirth. These results (a higher ratio in relation to the maternal material and a faster disappearance from the maternal circulation) demonstrate practical superiority of the search for fetal DNA in maternal plasma in relation to the preparation of fetal cells isolated from maternal whole blood (4, 7) .
APPLICATIONS
Many genetic diseases are caused by mutations that result in subtle differences between the sequences of maternal and fetal DNA, such as achondroplasia (8) and â-thalassaemia (9) . Many other clinical applications, especially for single gene disorders, have been described. We will discuss some applications that are important because of their incidence in the population. (10) . More recently, the TSPY gene has also been used in studies of small DNA samples (11) (12) .
Another application of fetal sexing is The affected boys present normal external genitalia.
Prenatal treatment of CAH with dexamethasone to
Cell-free fetal DNA in maternal... Ramos ES. Rev Latino-am Enfermagem 2006 novembro-dezembro; 14(6):964-7 www.eerp.usp.br/rlae prevent genital ambiguity has been successfully used (13) . However, to minimize the side effects, the to the degree of severity of the illness and, therefore, the level of fetal DNA may serve as a marker of the prognosis and severity of the clinical picture (7, 15) .
Although most researchers use the Y-chromosome in this specific application, other non-gender markers have been studied, including epigenetic markers, to improve the number of pregnant women that could be submitted to quantitative investigation (16) . As described by another group, the pregnant women may be interviewed and the sample blood can be taken in their homes by a nurse (17) . The introduction of new noninvasive techniques of prenatal diagnosis and the nursing team's knowledge about new methodologies for patient orientation can be of great benefit to mothers and children, and can help the genetic counseling of families.
DISCUSSION AND CONCLUSION
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